Interventional Cardiology Devices – Market Insights – Europe

The European IC device market has been able to recover from the COVID-19 pandemic and is seen as reverting to pre-pandemic sales. Steady uptake of several technologies has supported the IC device space and will continue to do so over the forecast period. In addition, premium priced advanced technologies are poised to enter the market, which could potentially change the existing treatment algorithms, disrupting the established category leaders.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for IC devices in Europe from 2019 through 2032.

The coronary stent segment is a highly competitive space, with the leading companies continuing to launch updates to their flagship devices.

How will the market landscape change over the next few years for coronary stents upon adoption of BRS?

Will the BRS market grow as well as DES?

What is the developmental pipeline for the next generation of BRS?

What factors are positively affecting the adoption of BRS in the European IC device market?

What competitive strategies are the major companies implementing to gain market share in this market?

The exclusive applicability of MDR in Europe will result in more stringent regulatory requirements.

What are the changes under the MDR that will affect the IC device market?

How will the UK Conformity Assessed requirements impact the European market going forward?

How will this impact pipeline products, and when are they expected to launch?

New technologies are expected to receive approval in the near future and change the way complex PCIs are diagnosed and treated.

What is the impact of the latest generation of alternative coronary physiology modalities such as resting index or imaging-based FFR_angio and FFR_CT on the patient and procedure in cardiac catheterization labs?

What are the recent events in the advanced diagnostic imaging space? How will these impact the existing players going ahead?

How will the emergence of alternative FFR modalities affect the FFR pressure guidewire market?

The European IC device market has been impacted by the COVID-19 pandemic.

What is the recovery outlook for 2022 and going forward?

Table of contents

Interventional Cardiology Devices - Market Insights - Europe

Anusha Naik

Anusha Naik is a member of the Cardiovascular Medtech Insights team at Clarivate, specializing in the heart valve device market. Anusha holds a Bachelor’s degree in Pharmaceutical Sciences from Goa College of Pharmacy, Goa and a Master’s degree in Pharmaceutical Quality Assurance from the Manipal Academy of Higher Education, Manipal.

Contact sales Login to access report

Back to all Medtech Insights reports